Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se Hoon Lee

Showing results (21-30 of 513) with videos related to

Pageof 52
Sort By:
Cancer Research and Treatment|June 15, 2018
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or ErlotinibYoujin Kim, Se-Hoon Lee, Jin Seok Ahn, et al.
Cancer Research and Treatment|February 18, 2015
Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single InstituteYounak Choi, Bhumsuk Keam, Tae Min Kim, et al.
Haematologica|March 1, 2006
The effect of pre-irradiation dose intense CHOP on anthracyline resistance in localized nasal NK/T-cell lymphomaSe-Hoon Lee, Yong Chan Ahn, Won Seog Kim, et al.
Respiratory Medicine|February 15, 2020
Development of tuberculosis in cancer patients receiving immune checkpoint inhibitorsYunjoo Im, Jeeyun Lee, Seok Jin Kim, et al.
Journal of Thoracic Disease|August 18, 2020
Are there any ethnic differences in the efficacy and safety of immune checkpoint inhibitors for treatment of lung cancer?Jiyun Lee, Jong-Mu Sun, Se-Hoon Lee, et al.
Translational Lung Cancer Research|October 19, 2023
Real-world clinical evidence of lazertinib use in acquired <i>EGFR</i> T790M mutated non-small cell lung cancerSehhoon Park, Hyun Ae Jung, Se-Hoon Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|September 16, 2015
Pemetrexed plus platinum versus pemetrexed alone in non-small cell lung cancer patients who have progressed after first-line EGFR TKIsSu Jin Lee, Jong-Mu Sun, Se Hoon Lee, et al.
The Korean Journal of Internal Medicine|November 11, 2015
Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failureKyoung Min Cho, Bhumsuk Keam, Tae Min Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2017
Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung CancerSong Ee Park, Se Hoon Lee, Jin Seok Ahn, et al.
The Korean Journal of Thoracic and Cardiovascular Surgery|February 13, 2018
Outcomes of Pulmonary Resection and Mediastinal Node Dissection by Video-Assisted Thoracoscopic Surgery Following Neoadjuvant Chemoradiation Therapy for Stage IIIA N2 Non-Small Cell Lung CancerYeong Jeong Jeon, Yong Soo Choi, Kyung Jong Lee, et al.
Pageof 52

Showing results (21-30 of 513) with videos related to

Sort By:
Pageof 52
Cancer Research and Treatment|June 15, 2018
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or ErlotinibYoujin Kim, Se-Hoon Lee, Jin Seok Ahn, et al.
Cancer Research and Treatment|February 18, 2015
Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single InstituteYounak Choi, Bhumsuk Keam, Tae Min Kim, et al.
Haematologica|March 1, 2006
The effect of pre-irradiation dose intense CHOP on anthracyline resistance in localized nasal NK/T-cell lymphomaSe-Hoon Lee, Yong Chan Ahn, Won Seog Kim, et al.
Respiratory Medicine|February 15, 2020
Development of tuberculosis in cancer patients receiving immune checkpoint inhibitorsYunjoo Im, Jeeyun Lee, Seok Jin Kim, et al.
Journal of Thoracic Disease|August 18, 2020
Are there any ethnic differences in the efficacy and safety of immune checkpoint inhibitors for treatment of lung cancer?Jiyun Lee, Jong-Mu Sun, Se-Hoon Lee, et al.
Translational Lung Cancer Research|October 19, 2023
Real-world clinical evidence of lazertinib use in acquired <i>EGFR</i> T790M mutated non-small cell lung cancerSehhoon Park, Hyun Ae Jung, Se-Hoon Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|September 16, 2015
Pemetrexed plus platinum versus pemetrexed alone in non-small cell lung cancer patients who have progressed after first-line EGFR TKIsSu Jin Lee, Jong-Mu Sun, Se Hoon Lee, et al.
The Korean Journal of Internal Medicine|November 11, 2015
Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failureKyoung Min Cho, Bhumsuk Keam, Tae Min Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2017
Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung CancerSong Ee Park, Se Hoon Lee, Jin Seok Ahn, et al.
The Korean Journal of Thoracic and Cardiovascular Surgery|February 13, 2018
Outcomes of Pulmonary Resection and Mediastinal Node Dissection by Video-Assisted Thoracoscopic Surgery Following Neoadjuvant Chemoradiation Therapy for Stage IIIA N2 Non-Small Cell Lung CancerYeong Jeong Jeon, Yong Soo Choi, Kyung Jong Lee, et al.
Pageof 52